Cardiovascular diseases (CVD) represent a major cause of mortality and morbidity
worldwide. To date, many physicians still requesting traditional lipid profile tests (TG, TC …

Although the available evidence emphasizes the beneficial effects of probiotics in
normalizing various cardiometabolic markers, there is still substantial uncertainty in this …

Background/purpose Cardiovascular disease (CVD) is the leading cause of death among
individuals with non-alcoholic fatty liver disease (NAFLD). Recently, NAFLD was renamed …

Background Due to the contribution of coronary artery disease (CAD) to serious
cardiovascular events, determining biomarkers that could robustly predict its risk would be of …

Purpose Polycystic ovarian syndrome (PCOS) is most commonly presented with insulin
resistance (IR). Simple anthropometric indices may serve as surrogate markers of these …

Abstract Introduction and Objectives Cardiovascular disease (CVD) is the major cause of
death in non-alcoholic fatty liver disease (NAFLD), a clinical condition without any approved …

Cardiovascular disease (CVD) is the leading cause of death in patients with non-alcoholic
fatty liver disease (NAFLD). Curcumin has been shown to exert glucose-lowering and anti …

Objective: to evaluate the correlation between a group of conventional biomarkers of
cardiovascular risk with the Castelli-I and Castelli-II indices, and TG/HDL-C ratio in patients …

Introduction: traditionally, non-communicable diseases were diseases of public health
concern in developed countries. Due to economic transition, they are becoming more …

Background Adverse childhood experiences (ACE) have been associated with poor later life
health outcomes, including cardiovascular disease (CVD). Limited research investigating …